Small effects of smoking on visual spatiotemporal processing by Kunchulia, Marina et al.
Small effects of smoking on visual
spatiotemporal processing
Marina Kunchulia1, Karin S. Pilz2 & Michael H. Herzog3
1Institute of Cognitive Neurosciences, Agricultural University of Georgia, Tbilisi, Georgia, 2School of Psychology, University of
Aberdeen, Scotland, UK, 3Laboratory of Psychophysics, Brain Mind Institute, School of Life Sciences, Ecole Polytechnique Federale
de Lausanne (EPFL), Switzerland.
Nicotine is an important stimulant that is involved inmodulatingmany neuronal processes, including those
related to vision. Nicotine is also thought to play a key role in schizophrenia: A genetic variation of the
cholinergic nicotine receptor gene, alpha-7 subunit (CHRNA7) has been shown to be associated with
stronger backward masking deficits in schizophrenic patients. In this study, we tested visual backward
masking in healthy smokers and non-smokers to further understand the effects of nicotine on
spatiotemporal vision. In the first study, we tested 48 participants, a group of non-smokers (n512) and three
groups of regular smokers that were either nicotine deprived (n512), non-deprived (n512) or deprived but
were allowed to smoke a cigarette directly before the start of the experiment (n512). Performance was
similar across groups, except for some small negative effects in nicotine-deprived participants. In the second
study, we compared backward masking performance between regular smokers and non-smokers for older
(n537, 13 smokers) and younger (n567, 21 smokers) adults. Older adults performed generally worse than
younger adults but there were no significant differences in performance between smokers and non-smokers.
Taken together, these findings indicate that nicotine has no long-term negative effects on visual
spatiotemporal processing as determined by visual backward masking.
N
icotine is a psychoactive component of tobacco that affects the central nervous system and is the third
most prevalent freely accessible drug after alcohol and caffeine. Nicotine has many negative effects on
health as, for example, an increased risk for stroke, cancer, heart diseases and a variety of ocular
diseases1–7. Interestingly, however, nicotine has been shown to have positive effects on cognition and it has been
suggested that nicotine addiction may partly relate to its cognitive-enhancing effects8–12. For example, nicotine
has been shown to improve memory functions13–15 and smokers have reported beneficial effects of smoking on
concentration and memory16–18. In addition, it has been shown that nicotine abstinence in smokers is associated
with decreased cognitive functions including impairments of sustained attention and poorer working
memory19–24.
The effects of smoking on vision are largely understudied and to the best of our knowledge, no study has tested
whether and how nicotine affects visual temporal processing or the relationship between nicotine addiction and
visual temporal processing.
A powerful paradigm that is often used to study visual temporal processing is visual backward masking: A
target stimulus is followed by a mask that alters the visibility of the target. A very sensitive variation of backward
masking is the shine throughmasking paradigm25–27. In this paradigm, participants have to discriminate the offset
direction of a vernier stimulus that precedes amask grating of 25-elements (Figure 1). A vernier stimulus consists
of two abutting bars, of which the lower bar can be offset to the right or left. When masked with a 25-element
grating, the vernier is perceived as beingwider and brighter than it really is and appears to be superimposed on the
grating (Figure 1). The vernier duration and the spatial offset between the two bars are adjusted individually
before adding a mask so that participants can easily discriminate the offset direction. The stimulus onset asyn-
chrony (SOA) between vernier and grating is then used as a measure for the strength of the masking effect:
Longer SOAs indicate strong masking effects, whereas shorter SOAs indicate weaker masking effects. If the
grating has only 5-elements, shine-through does not occur and the vernier is almost invisible even though the
5-element grating is contained within the 25-element grating. Only when the SOA is increased for the 5-
element grating, the vernier becomes visible again, indicating stronger masking effects for the 5-element than
the 25-element grating. Shine-through is affected by both temporal and spatial alterations of the grating. For
example, when adding spatial inhomogeneities, such as gaps close to the center of the 25-element grating, the
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grating between the vernier and the larger grating can dramat-
ically deteriorate performance27. The shine-through effect is
related to the grouping of the mask: Only if the grating is per-
ceived as a homogeneous and extended object, shine-through
occurs. However, if spatial or temporal inhomogeneities segment
the extended grating into smaller parts, the shine-through effect is
decreased or even extinguished (Figure 1).
The shine-through paradigm is a powerful tool to assess visual
spatiotemporal processing in special populations. For example,
Overney et al.28 showed enhanced temporal processing in tennis
players compared to non-athletes and triathletes and Kunchulia et
al.29 found that alcohol strongly deteriorates performance. In addi-
tion, there are tremendous changes in schizophrenic patients who
show increases in SOA of about a factor of five compared to healthy
controls and interestingly, also the healthy relatives of the patients
are affected30,31.
Bakanidze et al.32 found a direct association between a genetic
variation of the cholinergic nicotine receptor gene, alpha-7-subunit
(CHRNA7) and the shine-through effect in schizophrenic patients.
These results are in accordance with the hypothesis that the nicotinic
system plays a key role in the pathophysiology of schizophrenia33–35.
Many schizophrenic patients are heavy smokers36–39 and smoking
has been related to attentional enhancements in schizophrenic
patients39 supporting the idea that smoking is a form of self-
medication39–43.
The purpose of this study was two-fold: First, we were interested in
the effects of smoking on spatiotemporal processing in general and,
second, we were particularly interested whether nicotine has similar
effects on backward masking as it has been found in schizophrenic
patients. In short, the reasoning is as follows: Shine-through is
diminished in schizophrenia. The nicotine system has been directly
linked to schizophrenia and many schizophrenic patients are heavy
smokers, which is thought to be a form of self-medication. Nicotine
has been shown to have cognitive-enhancing effects. Here we tested
whether nicotine also has positive affects on visual processing in
healthy participants. In part one, we compared performance of
non-smokers to smokers, deprived smokers and smokers who were
allowed to smoke a cigarette directly before the experiment. Since
smoking seems to have positive effects in schizophrenia, we expected
improvements in backward masking for regular smokers and
deprived smokers that were allowed to smoke a cigarette directly
before the experiment compared to non-smokers and deprived
smokers30,31.
It has been shown that smoking increases the risk for developing
Alzheimer’s disease and age-related cognitive decline44. In addition,
smoking has been shown to affect age-related eye diseases including
age-related macular degeneration45. Interestingly, nicotinic acet-
ylcholine receptors have been found to decline with age46.
Consequently, the effects of smoking on backward masking might
change during ageing. Therefore, in order to investigate the long-
term influence of smoking on backward masking, we compared
healthy younger and older smokers and non-smokers in part two
of the study. In both parts of the study, effects were relatively small.
Results
There were no significant differences for vernier duration (VD),
stimulus onset asynchrony for the 5-element grating (SOA5), or
the 25-element grating (SOA25) between men and women and
therefore, results for both sex groups are reported together.
Vernier duration. In part one of the study, vernier duration (VD),
the duration of the vernier at which participants could discriminate
the offset at 75% correct, was similar for all participants. All subjects
had a vernier duration of 20 ms, apart from onemale and one female
subject in the deprived1 group who had a vernier duration of 30 ms.
In part two of the study, a 2(Age) x 2 (Smoking) ANOVA showed a
main effect of Age (older adults: M 5 113.2, SD 5 147.2; younger
adults: M5 30.7, SD5 42.6; F(1,100)5 18.2, p,0.001). The vernier
durations for younger adults in part two of the study were notably
larger than in part one. This was mainly due to four younger parti-
cipants having vernier durations of 150 ms or above and one with a
vernier duration of 50 ms. All other younger participants (n562)
had a vernier duration of 20 ms. There were no other main effects or
interactions (Figure 2, left). Overall, only five out of 67 young parti-
cipants had a VD larger than 20 ms, whereas 20 out of 37 older
participants had a VD larger than 20 ms.
BackwardMasking. In part one of the study, ANOVAs on the factor
Group showed no significant difference between groups for SOA25
(F(3,44) 5 0.6, p 5 0.6) and only a marginal difference for SOA5
(F(3,44)5 2.7, p5 0.055) as shown in Figure 3 (left). Post-hoc tests
showed that deprived smokers had stronger masking effects than
Figure 1 | Shine-through. A vernier is presented for a short time and followed by a grating comprising more than 25 elements. The foregoing vernier
appears to be superimposed on the grating, looking wider, brighter, and for some observers, even longer. (B) For a grating with five elements, the visibility
of the preceding vernier is strongly diminished. (C) Visibility is also strongly diminished if the extended grating contains gaps (gap grating) or (D) a five-
element grating presented for 20 ms precedes the 5-25-elements grating (see scale on the right for timing in this condition). The interstimulus
interval (ISI) denotes the time difference between vernier offset and grating onset, while the stimulus onset asynchrony (SOA) denotes the difference
between vernier and grating onsets. The bottom row shows the percept. The vernier offset shown is strongly exaggerated. The spacing between grating
elements is 2000, whereas the vernier offsets are often much smaller. Figure adapted from Herzog et al.30
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deprived1 smokers (t(22) 5 2.8, p 5 0.006; Bonferroni corrected
alpha of 0.008 (0.05/6)). There was no other significant difference
with p.0.3 for all other comparisons.
In part two of the study, A 2(Age) x 2 (Smoking) ANOVAon SOA25
and SOA5 showed a main effect of Age (SOA25: older adults (M 5
94.55, SD5 154.95), younger adults (M5 36.93, SD5 51.87), F(1,100)
5 7.8, p, 0.01; SOA5: older adults (M5 198.97, SD5 150.9), younger
adults (M5 90.79, SD5 51.9), F(1,100)5 30, p, 0.001). There were
no other main effects or interactions (Figure 2, right).
Inhomogeneous Masks. Inhomogeneous masks were only tested in
part one. An ANOVA on the factor Group showed no significant
difference between groups for the gap grating (F(3,44) 5 1.44, p 5
0.244) or the 5–25 grating (F(3,44)5 0.65, p5 0.59). However, there
was a significant main effect of group for the 25 grating (F(3.44) 5
3.3, p,0.05)(Figure 3, left). Post-hoc tests showed that non-smokers
showed significantly less masking than deprived1 (t(22)51.8,
p,0.05) or non-deprived smokers (t(22) 5 2.5, p,0.01); however,
these effects did not survive a Bonferroni corrected alpha of 0.008
(0.05/6). There was no difference between non-smokers and
deprived smokers (t(22) 5 0.9, p 5 0.18).
Fagerstrom Test of Nicotine Dependence. The Fagerstrom Test of
Nicotine Dependence (FTND)47, was administered to all participants
before the experiment. Participants in the smoking groups had range
of FTND score from 5 to 10 and, on average, all smoking groups had
scores above 6 (deprived: M5 6.9 (0.5); Deprived1: M5 6.3 (0.3);
Non-deprived:M5 6.2 (0.3)), which is a score related tomoderate to
heavy smoking habits. A Pearson correlation showed no correlation
between test scores and SOA (Figure 4).
Discussion
Abnormalities in the nicotinic system have been linked to schizo-
phrenia. For example, the number of hippocampal nicotinic recep-
tors is reduced in schizophrenic patients33 and changing the
properties of nicotinic receptors has been suggested as a potential
treatment for schizophrenia34,35. In vision research, Bakanidze et al.32
recently found that a mutation of the cholinergic nicotine receptor
gene, alpha-7 subunit (CHRNA7) was correlated with schizophrenia
and performance in the shine-through masking paradigm.
Schizophrenic patients are often heavy smokers, which has been
suggested to be a form of self-medication39–43. Given these relation-
ships between nicotine, schizophrenia, and backward masking, we
Figure 2 | Vernier duration for older and younger smokers and non-smokers in part two of the study (left). Error bars depict standard error of the mean
(SE). There was only a significant difference between age-groups but no main effect of Smoking and no Age x Smoking interaction. SOAs for 5-
(middle) and 25- element gratings (right) for older and younger smokers and non-smokers in part two of the study. Error bars depict standard errors of
the mean (SE). There was only a significant difference between age-groups but no main effect of Smoking and no Age x Smoking interaction interaction.
Figure 3 | SOAs for 5- and 25- element gratings (left) for all participant groups. Error bars depict standard errors of the mean (SE). Deprived smokers
showed significantly higher masking than deprived1 smokers in the SOA5 condition. Thresholds (arc sec) for the 25 grating, gap grating, and 5-25
grating (right).
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investigated the relationship between nicotine and visual backward
masking in healthy observers.
In general, we found only small effects of nicotine on masking. In
the first part of this study, we tested non-smokers and three groups of
smokers (deprived, non-deprived and deprived1) in the shine-
through masking paradigm25–27. Only the comparison between
stimulus onset asynchronies 5 (SOA5) in the deprived and the
deprived1 group was significant. In the second part of this study,
we compared older and younger smokers and non-smokers. We
found a main effect of age, in line with a previous study on backward
masking and healthy ageing48, but no significant effect of smoking; if
any, smokers performed better than controls.
For inhomogeneous masks, thresholds for the gap and the 5-25
grating were different from the 25-element grating for all participant
groups indicating intact spatiotemporal processing. The rationale is
as follows: If spatial low pass filtering of the stimulus, for example,
due to blurred vision, had decreased the visibility of the gap, we
would have expected decreased thresholds, i.e., improved perform-
ance. Similarly, if temporal processing had been affected, we would
have expected decreased thresholds for the 5-25 grating. Shine-
through does not occur for the 5-element grating25 and hence, good
performance indicates that the shortly presented 5-element grating
has not been processed efficiently.We found a significant main effect
of smoking on the 25-element grating and post-hoc tests indicated
that deprived1 and non-deprived smokers showed more masking
than non-smokers. However, the post-hoc tests did not survive
Bonferroni correction. Future studies with larger sample sizes might
need to clarify whether the main effect of group was due to noise or
sample size. If the effects were true, it would indicate that smoking
negatively affects temporal processing. If these effects were due to
noise, it would indicate intact spatial and temporal visual processing
across all groups, which again, is comparable to studies with schizo-
phrenic patients who also have intact and fast perceptual grouping
and figure-ground segmentation even though SOAS are a factor of 4
higher compared to controls26. The notion that nicotine consump-
tion has no effect on visual processing is supported by a study of
Colzato et al.49, who showed that in healthy non-smokers nicotine
consumption did not affect visual feature integration.
One reason for the small effects of smoking on masking might be
that we deprived smokers for only 2 hours prior to the experiment.
However, Hendricks et al.50 showed that nicotine-dependent smo-
kers showed difficulties maintaining attention already 30 minutes
after their latest cigarette. In addition, all smokers of our study were
smoking at least 20 cigarettes per day and their scores on the
Fagerstrom Test for Nicotine Dependence (FTND)47 were at or
above 5, indicating amoderate to heavy level of nicotine dependence.
Therefore, we expected a 2 h nicotine deprivation to be enough for
inducing changes in nicotine-related mechanisms involved in back-
ward masking.
Another reason for not finding performance differences between
smokers and non-smokers might be that the nicotinic system of the
smokers has adapted to the permanent supply of nicotine. This
would also explain why we did not find superior performance in
the deprived1 smokers compared to non-smokers. Interestingly,
there seems to be a potential benefit of smoking in older adults, as
seen in the second part of the study. Future studies with more parti-
cipants are needed to clarify this. A more promising approach to test
the effects of nicotine on backward masking might be to administer
nicotine directly to non-smokers by using nicotine patches.
It has been suggested that nicotine is involved in visuospatial
attention and inhibition. However, results vary tremendously
between studies and it is difficult to generalize across studies given
the difference in experimental procedures. Hahn et al.51, for example,
administered nicotine or placebo patches to minimally deprived
smokers and found that the administration of nicotine improved
visuospatial attention. Vossel et al.52 administered nicotine or pla-
cebo chewing gums to non-smoking participants and also found an
advantage for participants that had received nicotine. Logeman
et al.53, however, tested non-smokers and deprived smokers that
had been administered with nicotine or placebo chewing gums
before the start of the session and found no behavioural differences
between groups in a visuospatial cueing paradigm. Similarly, Impey
et al.54 administered nicotine or placebo chewing gums to non-smo-
kers and also found no behavioural effects on spatial cueing. Taken
together, these studies highlight the inconsistency in results follow-
ing nicotine deprivation or administration to smokers and non-smo-
kers on visuospatial cueing tasks and support our hypothesis that
potential effects of smoking on visuospatial processing are small.
In conclusion, we only found a small relationship between nic-
otine deprivation and performance in backward masking. In addi-
tion, our results from part two suggest that nicotine has no negative
long-term effect on backward masking performance.
Methods
Participants. Informed consent was obtained from all participants. All procedures
involved in this study were approved by the Georgian National Bioethics Committee
and were performed in accordance with the Declaration of Helsinki. All participants
reported no mental, neural, or general health problems. All observers had normal or
corrected-to-normal vision as determined by a score larger than 0.8 in the Freiburg
visual acuity test55.
In part one of the study, 36 (18 female/18male) cigarette smokers and 12 (6 female/
6 male) non-smokers age from 20 to 40 years were recruited (mean age5 28.5 years,
Figure 4 | Top: Correlations of the Fagerstrom Test of Nicotine Dependence score (FTND) with SOA25 (left) and SOA5 (right). None of the
correlations is significant. Note the different scales of the y-axes.
www.nature.com/scientificreports
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STD5 5 years). Participants were asked to abstain from alcohol for 24 hrs and any
other psychotropic drugs for 48 hrs prior to the testing session.
All subjects took part in the Fagerstrom Test of Nicotine Dependence (FTND)47,
which tests the level of nicotine addiction. To take part in the experiment observers
had to score at least 5 in the FTND, indicating frequent smoking of about 20 cigarettes
a day.
We tested 4 groups of participants: a) Nicotine deprived subjects who were not
allowed to smoke 2 hours prior to testing and until the end of the experiment
(deprived, n5 12, mean age5 27.3 years, STD5 5.3, 6 male); b) Nicotine deprived
subjects whowere not allowed to smoke 2 hours prior to testing but had to smoke one
cigarette right before the start of the experiment (deprived1, n5 12, mean age525.7
years, STD54.35, 6male); c)Non-deprived smokers whowere allowed to smoke right
until the start of the experiment (non-deprived, n5 12, mean age5 30.7 years, STD
5 4.95, 6 male); d) Non-smokers who had never smoked a cigarette (non-smokers,
n 5 12, mean age 5 29.4 years, STD 5 5.67, 6 male). There was no difference in
FTND scores between the three groups of smokers who took part in this experiment
(F(2,33)5 0.77, p5 0.47). There were also no significant age differences between all
groups of participants (F(3,44) 5 2.49, p 5 0.07).
In part two of the study, we compared 13 older smokers (mean age5 64 years, STD
5 2.4, 5 male, mean years of smoking 5 43.1, STD 5 6.5), 24 older non-smokers
(mean age 5 65.87 years, STD 5 5.2, 4 male), 21 younger smokers (mean age 5 22
years, STD5 2.4, 11 male, mean years of smoking5 5.4, STD5 2.1) and 46 younger
non-smokers (mean age5 21.8 years, STD5 2.5, 9 male). Older participants did not
show any signs of mild cognitive impairment as tested with the Montreal Cognitive
Assessment (MoCa)56.
None of the participants from study two had been involved in part one of the study.
Stimuli and Apparatus. For both parts of the study, stimuli and apparatus were
similar to Herzog et al.30.
The stimuli consisted of white vertical verniers and gratings comprising either 25
or 5 aligned verniers presented on a black background. A vertical vernier was com-
posed of two bars that were slightly displaced in the horizontal direction either to the
left or to the right. The length of a segment of the vernier, i.e. one bar, was 10 arc min.
Segments were separated by a small gap of 1 arc min. The aligned verniers of the
gratings had the same lengths as the verniers. The horizontal distance between grating
elements was about 3.33 arc min. The vernier and the central element of the grating
always appeared in the middle of the screen. The stimuli appeared on a Samsung
SyncMaster 957 DF CRT screen with a 100 Hz refresh rate. Maximal screen lumin-
ance was about 100 cd/m2 as measured with a GretagMacbeth Eye-One Display 2
colorimeter. The background luminance on the screen was below 1 cd/m2. Observers
were seated in a dimly lit room at 5 m from the monitor.
Procedure. For both parts of the study, the procedure was similar toHerzog et al.30. In
the first step, we determined vernier duration (VD) using unmasked verniers.
Verniers were presented in the middle of the screen and observers had to determine
the offset direction (left or right) of the lower bar. For each observer, we determined
the shortest VD for which the offset discrimination threshold (75% correct
discrimination) was below 400 (arc sec)29–32. Vernier duration was constant in each
block andwe varied the offset of the vernier using the adaptive PEST procedure. In the
first block, verniers were presented for 150 ms. In the following blocks, vernier
duration was reduced when the threshold for offset discrimination was below the
predefined value of 400 and increased when the threshold for offset discrimination
was above 400. Each block consisted of 80 trials.
After the individual VD was determined, the nicotine-deprived1 participants had
to smoke one cigarette within 5 minutes. Five minutes after the intake of nicotine, we
started with the next step of the experiment. Participants from the other three groups,
non-smokers, non-deprived smokers and nicotine-deprived had a 10 minute break
between step one and two. In the second step, individual vernier durations, as
determined in step one, were used for each participant. We determined stimulus-
onset asynchronies (SOAs) for backward masking using the adaptive PEST proced-
ure57. The SOA is defined as the difference between grating and vernier onset and is
the sum of vernier duration and ISI (SOA5 vernier duration1 ISI). The grating was
comprised of either 5 or 25 aligned verniers, i.e., verniers with out offset. The aligned
verniers had the same lengths as the verniers. The horizontal distance between grating
elements was about 3.33 arc min. The vernier and the central element of the grating
always appeared in the middle of the screen and gratings lasted for 300 ms. We
adaptively assessed the stimulus-onset-asynchrony (SOA) between target and mask.
For each observer, we used the individual vernier duration as determined in step one.
The vernier offset size was set to 71029-32. The SOA was varied from trial to trial. We
determined the critical SOA for which a performance level of 75% correct responses
was obtained with a probit model using a standard maximum likelihood proced-
ure58,59. After each response, the SOA was adjusted based on the estimated model
parameters until the model reached its terminus at 75% correct. The starting value of
the SOA was set to 200 ms. For each grating two thresholds were determined. The
mean of the two thresholds was taken as the critical SOA. If observers were unable to
reach a threshold value of 400 ms or below, a value of 450 ms was recorded (for
details see26).
Only in part one, we included a third step, in which we tested performance for three
inhomogeneous masks. We used the individual SOA and vernier durations deter-
mined in steps one and two. Therefore, baseline performance should be comparable
across all observers. We determined individual vernier offset discrimination thresh-
olds using the adaptive PEST strategy57. In the first condition, we presented the
standard 25-element grating for 300 ms as described above. In the second condition,
we presented a 25-element grating for 300 ms, in which the middle two lines were
removed (gap grating). The gap width was 2500 and separated the central 5-elements
from the peripheral 2*10 elements. In the third condition, we presented a 25-element
grating for 280 ms, which was preceded by a 5-element grating for 20 ms (5-25
grating). Hence, duration of the combined gratings was 300 ms as was the pre-
sentation time for conditions 1 and 2.
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